H. C. Schaller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
H. C. Schaller has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
L. J. Chassin
Diabetes Modelling Group, Department of Paediatrics, University of Cambridge, Cambridge, UK, and
1 shared publicationL. Schaupp
Department of Biophysics, Institute of Biomedical Engineering, University of Technology Graz and
1 shared publicationM. E. Wilinska
Diabetes Modelling Group, Department of Paediatrics, University of Cambridge, Cambridge, UK, and
1 shared publication- Manfred Bodenlenz
HEALTH-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010, Graz, Austria
1 shared publication P. Wach
Department of Biophysics, Institute of Biomedical Engineering, University of Technology Graz and
1 shared publication- Roman Hovorka
Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
1 shared publication
Latest Publications
- 6 January 2006
- Published by Wiley in Diabetic Medicine
- Vol. 23 (1) , 90-93
On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes
Aims To evaluate an algorithm with glucose prediction capacity and continuous adaptation of patient parameters—a model predictive control (MPC) algorithm—to control blood glucose concentration during fasting conditions in patients with Type 1 diabetes. In the subcutaneous (sc) route within a closed loop system.Methods Paired experiments were performed in six patients. Over 8 h the MPC algorithm was used to control glucose with s.c. insulin administration and two different glucose monitoring protocols: first, the algorithm was provided with intravenous (i.v.) glucose values for insulin dosage calculation directly (i.v.–s.c. route). Then, in the second experiment, i.v. glucose values were fed to the MPC with a delay of 30 min to simulate s.c. glucose measurements (‘s.c.’–s.c. route). In both experiments plasma glucose, insulin dosage, and serum insulin levels were analysed.Results Glucose concentration was brought from hyper‐ to normoglycaemia and kept in the physiological range (6–7 mmol/l) with both routes in all subjects. Mean glucose concentration reached the threshold of 7 mmol/l approximately 2 (i.v.–s.c. route) and 3 (‘s.c.’–s.c. route) hours after the start of glucose control with the MPC. During the last 2 h of automated glucose control, mean glucose concentration was 6.3 ± 0.2 mmol/l and 6.6 ± 0.3 mmol/l for i.v.–s.c. and ‘s.c.’–s.c. route, respectively. Glucose concentration, insulin doses, and serum insulin levels did not differ significantly between routes (P > 0.05).Conclusions The MPC algorithm is suitable for glucose control during fasting within an extracorporeal artificial β‐cell in the subcutaneous route Type 1 diabetic patients.
- 6 January 2006
- Published by Wiley in Diabetic Medicine
- Vol. 23 (1) , 90-93
On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes
Aims To evaluate an algorithm with glucose prediction capacity and continuous adaptation of patient parameters—a model predictive control (MPC) algorithm—to control blood glucose concentration during fasting conditions in patients with Type 1 diabetes. In the subcutaneous (sc) route within a closed loop system.Methods Paired experiments were performed in six patients. Over 8 h the MPC algorithm was used to control glucose with s.c. insulin administration and two different glucose monitoring protocols: first, the algorithm was provided with intravenous (i.v.) glucose values for insulin dosage calculation directly (i.v.–s.c. route). Then, in the second experiment, i.v. glucose values were fed to the MPC with a delay of 30 min to simulate s.c. glucose measurements (‘s.c.’–s.c. route). In both experiments plasma glucose, insulin dosage, and serum insulin levels were analysed.Results Glucose concentration was brought from hyper‐ to normoglycaemia and kept in the physiological range (6–7 mmol/l) with both routes in all subjects. Mean glucose concentration reached the threshold of 7 mmol/l approximately 2 (i.v.–s.c. route) and 3 (‘s.c.’–s.c. route) hours after the start of glucose control with the MPC. During the last 2 h of automated glucose control, mean glucose concentration was 6.3 ± 0.2 mmol/l and 6.6 ± 0.3 mmol/l for i.v.–s.c. and ‘s.c.’–s.c. route, respectively. Glucose concentration, insulin doses, and serum insulin levels did not differ significantly between routes (P > 0.05).Conclusions The MPC algorithm is suitable for glucose control during fasting within an extracorporeal artificial β‐cell in the subcutaneous route Type 1 diabetic patients.